Search
Print Page   |   Contact Us   |   Sign In   |   Join Today
News & Press: Company News

Intrexon Closes $230 Million Public Offering of Common Stock

Wednesday, August 26, 2015  
Share |
Intrexon Corporation, a leader in synthetic biology, closed its previously announced public offering of common stock, including the exercise in full by the underwriters of their option to purchase an additional 731,707 shares of common stock at the public offering price of $41.00 per share. The exercise of the underwriters' option brought the total number of shares of common stock sold by Intrexon to 5,609,756 shares and increased the total gross proceeds raised in the offering to approximately $230 million, before deducting the underwriting discounts, commissions, and estimated expenses.

JMP Securities LLC acted as sole book-running manager for the offering. Stifel acted as lead manager for the offering. Griffin Securities and Wunderlich Securities acted as co-managers for the offering.

more Events

12/12/2016 » 12/14/2016
ISBioTech 4th Fall Meeting

12/14/2016
Webinar; Investor Tax Credits

Premium Members

Membership Software Powered by YourMembership  ::  Legal